The ALTITUDE-AD Study
Help us learn more about an investigational drug for early Alzheimer’s disease.
Before a new medication can be approved for public use, researchers must learn more about it through clinical research studies, also referred to as clinical trials. Clinical trials gather valuable information that could lead to better treatments and, with the right breakthrough, better outcomes.
Informed consent is a process in which the study team gives you information about a clinical trial so you can decide whether you want to participate in it.
Before you decide to join a clinical trial, you may want to discuss the study information with your doctor or other healthcare professionals and with your family members and friends.
Answer the questions below to see whether you or your loved one may qualify to participate in the ALTITUDE-AD Study. Answering these questions does not obligate you to participate in the study. If you are interested in participating, you will receive more information to help you determine if you would like to enroll in the study.
Your answers will be recorded, but your information will be used only for the purposes of the study and will not be shared without your permission, unless required by law.
Are you between the ages of 50 and 90 years?
Are you experiencing memory loss?
Do you have a confirmed or suspected diagnosis of mild cognitive impairment or mild dementia due to Alzheimer’s disease? (A current diagnosis is not required for study participation.)
Do you have a study partner, such as a spouse, family member, or friend, who can attend some of the study visits?
204-1353 Ellis St
Kelowna, British Columbia V1Y 1Z9
250-862-8141
1 Valleybrook Dr
Suite 400
Toronto, Ontario M3B 2S7
416-386-9761
1600 Carling Ave
Ottawa, Ontario K1Z1G3
1-613-702-1000
168 Brock St
Peterborough, Ontario K9H 2P4
1-705-749-3906
4892-4896 Taschereau Blvd
Suite 230
Greenfield Park, Quebec J4V 2J2
450 672-7766 #223